首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1316238

全球心导管和导丝市场 - 2023-2030 年

Global Cardiac Catheters and Guidewires Market - 2023-2030

出版日期: 2023年07月27日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

2022 年，全球心导管和导丝市场规模达到 136 亿美元，预计到 2030 年将实现 243 亿美元的强劲增长。在预测期内（2023-2030 年），全球心导管和导丝市场的复合年增长率预计将达到 7.7%。

心导管和导丝市场包括为特定诊断或介入手术而设计的各类导管。其中包括血管造影导管、球囊导管、电生理导管和血管内超声（IVUS）导管等。每种导管在诊断、存取或治疗心血管疾病方面都有其独特的作用。

受心血管疾病发病率上升、技术进步以及向微创手术转变等因素的影响，全球心导管市场正呈现稳步增长态势。在心血管疾病的精确诊断和有效治疗需求不断增长的推动下，预计未来几年市场将继续保持增长态势。

市场动态

微创手术的增加推动导管和导丝市场的增长

据 Biomed Central 报道，2022 年 9 月，一篇名为《微创心脏外科》的文章对影响和力量进行了文献计量分析，以确定促进高级培训的关键因素。从 20 世纪 90 年代中期开始，微创技术不断发展，包括微型胸骨切开术和微型胸廓切开术。

随着研究和开发的不断深入，MICS 将在心胸外科培训中得到高度普及，而确定关键的研究领域将有助于指导未来的培训和研究。

有利的报销政策推动了心脏导管和导丝市场的增长

报销政策规定了特定心导管手术向医疗服务提供者提供的报销额度。这些政策通常会考虑手术的复杂程度、使用的导管类型以及手术过程中使用的相关医疗资源等因素。报销政策在心导管市场中起着至关重要的作用，因为它们决定了医疗服务提供商在实施心导管手术时的覆盖范围和经济补偿水平。

例如，根据冲击波医疗公司（Shockwave Medical）的数据，2022 年 7 月 1 日，自 2021 年初推出冠状动脉 IVL 以来，冲击波公司在报销方面取得了重大进展。他们在门诊、ASC 和住院方面都获得了报销。

心导管手术的高并发症风险将阻碍市场增长

心导管检查需要将导管插入血管，这有可能造成血管损伤。这可能包括血管穿孔、剥离（血管壁撕裂）或破裂。血管损伤可能导致出血、血肿形成，甚至需要手术修复。导管内部或周围可能会形成血栓，从而导致潜在的并发症。血栓会阻碍血流，导致患处缺血或梗塞。为防止血栓形成，可在手术前、手术中或手术后服用抗凝药物或抗血小板药物。

据 CardioVascular Group 2023 年 4 月 14 日报道，心导管手术最常见的风险是出血。在手术过程中，需要切开一个小口来插入导管，这可能会导致出血。有时，插入部位周围会形成血肿或血液聚集。这可能会造成疼痛，并可能需要进一步治疗。

心导管手术的另一个风险是感染。由于手术需要进入血液，因此有感染的风险。心导管检查过程中或之后可能会出现称为心律失常的心律异常。这可能是手术过程中血流变化或导管与心肌摩擦造成的。大多数心律失常都很轻微，会自行消失，但偶尔也会有危险，需要就医。

COVID-19 影响分析

COVID-19 大流行对全球心导管和导丝市场产生了重大影响。由于封锁、旅行限制以及生产和分销中断，包括心脏导管和导丝在内的医疗器械全球供应链已经中断。这给某些医疗器械的供应和产品供应波动带来了挑战。

在大流行期间，患者可能会推迟定期体检和筛查，导致通常需要进行心导管手术的心血管疾病的检测和诊断率下降。患者就诊和筛查的减少影响了心导管和导丝的使用。

俄乌冲突分析

冲突造成了俄罗斯和乌克兰之间的地缘政治紧张局势、边界争端和贸易中断。这些干扰可能会对包括心脏导管设备在内的医疗设备供应链造成潜在影响。如果这些器械的进出口受到限制或延误，可能会导致供应短缺或延误，从而影响市场。

持续的冲突导致俄罗斯和乌克兰的经济不稳定。经济衰退和货币波动会对医疗保健行业，包括医疗器械市场产生连锁反应。医疗保健系统购买力下降和预算紧张可能会影响心脏导管和导丝的需求和采购。

在冲突时期，医疗保健的重点往往转向急诊和创伤护理，包括治疗与战争有关的创伤。这种重点转移可能会导致对非急诊医疗程序的重视程度降低，包括那些需要心脏导管设备的程序。随着资源转向更紧急的医疗保健需求，对此类设备的总体需求可能会受到影响。因此，考虑到上述因素，全球心脏导管和导丝市场受到俄罗斯和乌克兰冲突的影响不大。

Market Overview

The global cardiac catheters and guidewires market reached US$ 13.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 24.3 billion by 2030. The global cardiac catheters and guidewires market is expected to exhibit a CAGR of 7.7% during the forecast period (2023-2030).

The cardiac catheter and guidewire market encompass various types of catheters designed for specific diagnostic or interventional procedures. These include angiography catheters, balloon catheters, electrophysiology catheters, and intravascular ultrasound (IVUS) catheters, among others. Each type of catheter serves a unique purpose in diagnosing, accessing, or treating cardiovascular conditions.

The global cardiac catheter market is witnessing steady growth due to factors such as the increasing prevalence of cardiovascular diseases, technological advancements, and the shift toward minimally invasive procedures. The market is expected to continue its growth trajectory in the coming years, driven by the rising demand for accurate diagnosis and effective treatment of cardiovascular conditions.

Market Dynamics

Increasing Minimally Invasive Procedures Drives the Growth of Catheter and Guidewire Market

According to Biomed Central, in September 2022, an article named Minimally-invasive cardiac surgery conducted a bibliometric analysis of impact and force to identify key and facilitating advanced training which states that minimally-invasive techniques have started to become more prominent as cases become more complex. As of the mid-1990s there are been development of techniques to involve mini-sternotomy and mini-thoracotomy approaches.

With continued research and development, MICS is set to become highly prevalent in Cardiothoracic Surgery training and identifying key areas of research would help to guide training and research in the future.

Favorable Reimbursement Policies are Boosting the Cardiac Catheters and Guidewires Market Growth

Reimbursement policies define the amount of reimbursement provided to healthcare providers for specific cardiac catheterization procedures. These policies often consider factors such as the complexity of the procedure, the type of catheter used, and the associated healthcare resources utilized during the procedure. Reimbursement policies play a crucial role in the cardiac catheter market as they determine the level of coverage and financial reimbursement provided to healthcare providers for performing cardiac catheterization procedures.

For instance, according to Shockwave Medical for instance, on July 1 2022, since the launch of Coronary IVL in early 2021, Shockwave has made deep and significant progress on reimbursement. They have reimbursement in the outpatient, ASC, and inpatient setting.

High Risk of Complications for Cardiac Catheterization Will Hamper the Growth of the Market

Cardiac catheterization involves the insertion of a catheter into blood vessels, which can potentially cause vessel damage. This can include vessel perforation, dissection (tearing of the vessel wall), or rupture. Vessel damage can result in bleeding, hematoma formation, or even require surgical repair. Blood clot formation can occur within or around the catheter, leading to potential complications. Thrombosis can obstruct blood flow, resulting in ischemia or infarction in the affected area. To prevent thrombosis, anticoagulant medications or antiplatelet agents may be administered before, during, or after the procedure.

According to CardioVascular Group, April 14 2023, the most common risks associated with cardiac catheterization is bleeding. During the procedure, a small incision is made to insert the catheter, and this can lead to bleeding. Sometimes, a hematoma, or a collection of blood, can form around the insertion site. This can be painful and may require further treatment.

Another risk of cardiac catheterization is of infection. Since the procedure involves accessing the bloodstream, there is a risk of infection. Heart rhythm abnormalities called arrhythmias can happen during or after cardiac catheterization. These may result from changes in blood flow during the procedure or from the catheter rubbing against the heart muscle. The majority of arrhythmias are small and go away on their own, but they can occasionally be dangerous and need medical attention.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global cardiac catheters and guidewire market. The global supply chains for medical devices, including cardiac catheters and guidewires have been disrupted due to lockdowns, travel restrictions, and disruptions in manufacturing and distribution. This has led to challenges in the availability of certain medical devices and fluctuations in product supply.

During the pandemic, patients may have postponed regular check-ups and screenings, resulting in decreased detection and diagnosis of cardiovascular conditions that would typically require cardiac catheterization procedures. This decline in patient visits and screenings has impacted the utilization of cardiac catheters and guidewires.

Russia-Ukraine Conflict Analysis

The conflict has created geopolitical tensions, border disputes, and trade disruptions between Russia and Ukraine. These disruptions can potentially affect the supply chain of medical devices, including cardiac catheter devices. If there are restrictions or delays in the import/export of these devices, it could lead to shortages or delays in their availability, impacting the market.

The ongoing conflict has resulted in economic instability in both Russia and Ukraine. Economic downturns and currency fluctuations can have a ripple effect on the healthcare sector, including medical device markets. Reduced purchasing power and budgetary constraints within healthcare systems may impact the demand and procurement of cardiac catheters and guidewires.

During times of conflict, healthcare priorities often shift towards emergency and trauma care, including the treatment of war-related injuries. This shift in focus may result in a reduced emphasis on non-emergency medical procedures, including those requiring cardiac catheter devices. The overall demand for such devices could be impacted as resources are redirected towards more urgent healthcare needs. Therefore, considering the above factors, the global cardiac catheters and guidewires market has been moderately affected by the conflict between Russia and Ukraine.

Segment Analysis

The cardiac catheters and guidewires market is segmented based on product type, application, end-user, and geography.

Owing to the Increasing Prevalence of Cardiovascular Disease, Rising Clinical Trials, the Hospital Segment Accounted for Approximately 45.5% of the Cardiac Catheters and Guidewires Market Share

Hospitals are the primary users of cardiac catheters and guidewires as these devices are essential for performing various cardiovascular procedures. Hospitals generate demand for these devices based on their patient population and the prevalence of cardiovascular diseases in their region. Hospitals are responsible for the procurement and purchasing of cardiac catheters and guidewires. They establish contracts with medical device manufacturers and suppliers to ensure a steady supply of these devices for their cardiovascular departments.

For instance, on April 25 2022, New York-Presbyterian Hudson Valley Hospital launched Interventional Cardiology program and opens state-of-the-art cardiac catheterization lab. It is designed to support cardiac health and bring world-class interventional cardiology care to the Hudson Valley and upper Westchester region. The interventional cardiology program provides a variety of emergent procedures, including cardiac angioplasty to improve blood flow in narrow or blocked arteries for patients experiencing a heart attack or chest pain. Advanced cardiac services include diagnostic cardiac catheterization (a procedure in which a catheter is guided through a blood vessel in the heart to diagnose certain heart conditions) and minimally invasive procedures to open clogged arteries.

Geographical Analysis

North America Accounted for Approximately 39.4% of the Market Share in 2022, Owing to the Increasing Research and Development Activities and Well-Established Healthcare Infrastructure

North America plays a significant role in the cardiac catheter and guidewire market and is a major contributor to its growth. North America, particularly the United States, has a well-developed and advanced healthcare infrastructure. The region is known for its state-of-the-art medical facilities, highly skilled healthcare professionals, and advanced technologies.

This infrastructure supports the adoption and utilization of cardiac catheters in various cardiovascular procedures. It also has a high prevalence of cardiovascular diseases, including coronary artery disease, hypertension, and heart failure. These conditions often require diagnostic and interventional procedures, such as cardiac catheterization, to assess and treat the cardiovascular system. The increasing incidence of these diseases drives the demand for cardiac catheters in the region.

North America is home to several leading medical device manufacturers and market players in the cardiac catheter segment. These companies invest in research and development activities to introduce innovative catheter technologies, enhance procedural outcomes, and improve patient safety. The presence of these established market players further stimulates market growth.

For instance, on Feb 2, 2022. as part of its expanding line of electrophysiological products for the international market, Abbott announced two approvals. The business's TactiFlex Ablation Catheter, Sensor Enabled, the only ablation catheter in the world with a flexible tip and contact force sensing, has been granted CE Mark 1 for the purpose of treating patients with unnatural heart rhythms such atrial fibrillation (AFib). The U.S. Food and Drug Administration (FDA) recently granted an additional indication for using Abbott's FlexAbility Ablation Catheter, Sensor Enabled to treat patients with complicated cardiac conditions.

Competitive Landscape

The major global players in the market include: Abbott Healthcare Pvt. Ltd., Boston Scientific Corp, Biotronic, Medtronic, Terumo Medical Corporation Access, Cordis, Teleflex Inc., Nipro, BrosMed Medical co., Merit Medical System among others

Why Purchase the Report?

To visualize the cardiac catheters and guidewires market segmentation based on the product type, by application, by end-user and by region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of cardiac catheters and guidewires market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global cardiac catheters and guidewires market report would provide approximately 69 tables, 70 figures, and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Geography

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technology Advancements in Catheter and Guidewires
  - 4.1.1.2. Increasing Number of Clinical Trials on Cardiac Catheters and Guidewires
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Surgical Procedures and Cardiac Catheters
- 4.1.3. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario before COVID-19
- 6.1.2. Scenario during COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. Russia-Ukraine War Analysis

8. By Product type

8.1. Introduction
8.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.3. Market Attractiveness Index, By Product Type
8.4. Cardiac Catheters
8.5. Introduction
8.6. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.7. Cardiac Guidewires

9. By Application

9.1. Introduction
9.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3. Market Attractiveness Index, By Application
9.4. Balloon Septostomy
9.5. Introduction
9.6. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.7. Coronary Angioplasty
9.8. Catheter Ablation
9.9. Left/Right Heart Catheterization

10. By End Users

10.1. Introduction
10.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.3. Market Attractiveness Index, By End Users
10.4. Hospitals
10.5. Clinics
10.6. Ambulatory Surgery Centers

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Geography
  - 11.2.6.1. U.S.
  - 11.2.6.2. Canada
  - 11.2.6.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Geography
  - 11.3.6.1. Germany
  - 11.3.6.2. U.K.
  - 11.3.6.3. France
  - 11.3.6.4. Italy
  - 11.3.6.5. Spain
  - 11.3.6.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Geography
  - 11.4.5.1. Brazil
  - 11.4.5.2. Argentina
  - 11.4.5.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.5.1. China
  - 11.5.5.2. India
  - 11.5.5.3. Japan
  - 11.5.5.4. Australia
  - 11.5.5.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Abbott Healthcare Pvt. Ltd
- 13.1.1. Product Portfolio and Description
- 13.1.2. Financial Overview
13.2. Boston Scientific Corp
13.3. Biotronik
13.4. Medtronic
13.5. Terumo Medical Corporation
13.6. Cordis
13.7. Teleflex Inc
13.8. Nipro
13.9. BrosMed Medical Co
13.10. Merit Medical Sysytem

14. Appendix

14.1. About Us and Services
14.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球心导管和导丝市场 - 2023-2030 年

Global Cardiac Catheters and Guidewires Market - 2023-2030

市场概述

市场动态

微创手术的增加推动导管和导丝市场的增长

有利的报销政策推动了心脏导管和导丝市场的增长

心导管手术的高并发症风险将阻碍市场增长

COVID-19 影响分析

俄乌冲突分析

目 录

第 1 章：研究方法与范围

第2章：定义和概述

第3章：执行摘要

第四章：动态

第 5 章：行业分析

第 6 章：COVID-19 分析

第 7 章 ：俄乌战争分析

第8章：按产品类型划分

第九章：按应用分类

第10章：按最终用户分类

第 11 章：按地区

第 12 章 ：竞争格局

第 13 章 ：公司简介

第14章：附录